Search clinical trials for: Niraparib
Total 227 results
-
Qian QinJanssen, LP; UT Southwestern Comprehensive Cancer CenterNot yet recruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | BRIP1 Gene Mutation | PALB2 Gene Mutation | CHEK2 Gene Mutation | FANCA Gene Mutation | RAD51B Gene Mutation | RAD54L Gene Mutation | Metastatic Hormone-sensitive Prostate Cancer (mHSPC) | Deleterious HRR Gene Mutation
-
Ivy Brain Tumor CenterGlaxoSmithKlineNot yet recruitingGlioblastoma | Brain Tumor | GBM | Brain Neoplasms, Adult, Malignant
-
Ibrahim Halil SahinGlaxoSmithKlineNot yet recruitingMMR-D/MSI-H Colorectal CancersUnited States
-
Rohan GarjeJanssen Scientific Affairs, LLCNot yet recruitingCastration-resistant Prostate Cancer | Metastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
University College, LondonNovartis; Cancer Research UK; Janssen Pharmaceutica NVNot yet recruiting
-
Armando Santoro, MDGlaxoSmithKline; Istituto Clinico HumanitasNot yet recruiting
-
Korea University Anam HospitalTakeda; Korean Cancer Study GroupNot yet recruiting
-
University of Maryland, BaltimoreJanssen Scientific Affairs, LLCRecruitingProstate Cancer | Oligometastatic DiseaseUnited States
-
German Breast GroupGlaxoSmithKline; Stemline Therapeutics, Inc.Not yet recruitingBRCA1 Mutation | BRCA2 Mutation | PALB2 Gene Mutation | Hormone Receptor Positive HER-2 Negative Breast Cancer | Advanced or Metastatic Breast CancerGermany
-
MedSIRNot yet recruitingOvarian Cancer | Oligometastatic Disease | Serous Ovarian Tumor
-
Haider MahdiGlaxoSmithKline; Zenith EpigeneticsRecruitingOvarian Cancer | Recurrent Solid TumorsUnited States
-
Peking University Cancer Hospital & InstituteRecruitingOvarian, Fallopian Tube and Primary Peritoneal CarcinomaChina
-
GlaxoSmithKlineRecruiting
-
Peking Union Medical College HospitalRecruiting
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruiting
-
Fondation Ophtalmologique Adolphe de RothschildRecruiting
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustNot yet recruitingOvarian Cancer RecurrentUnited Kingdom
-
Sunnybrook Health Sciences CentreGlaxoSmithKlineRecruitingOvarian Cancer | Stage IV Ovarian Cancer | High Grade Ovarian Serous Adenocarcinoma | Stage III Ovarian CancerCanada
-
Casey CosgroveRecruitingRecurrent Endometrial Serous AdenocarcinomaUnited States
-
Latin American Cooperative Oncology GroupGlaxoSmithKlineRecruitingOvarian CancerArgentina, Brazil
-
Grupo Español de Tratamiento de Tumores de Cabeza...GlaxoSmithKline; MFARRecruitingHead and Neck Squamous Cell CarcinomaSpain
-
Ruijin HospitalNot yet recruiting
-
ETOP IBCSG Partners FoundationGlaxoSmithKline; Development LimitedRecruitingSCLC,Extensive Stage | SLFN11-positiveSwitzerland, France, Spain, Italy
-
M.D. Anderson Cancer CenterRecruiting
-
University of California, San FranciscoGlaxoSmithKlineRecruitingMetastatic Solid Tumor | BRCA1 Mutation | BRCA2 Mutation | PALB2 Gene Mutation | ATM Gene MutationUnited States
-
Mayo ClinicRecruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Not yet recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian CarcinomaUnited States
-
GOG FoundationGlaxoSmithKlineRecruitingStage IV Fallopian Tube Cancer | Stage IV Ovarian Cancer | Stage IV Primary Peritoneal Cancer | Stage III Ovarian Cancer | Stage III Primary Peritoneal Cancer | Stage III Fallopian Tube CancerUnited States
-
Sichuan Cancer Hospital and Research InstituteNot yet recruiting
-
UNICANCERCancer Research UK; National Cancer Institute, France; Servier; Pierre Fabre Medicament and other collaboratorsNot yet recruitingBiliary Tract NeoplasmsUnited Kingdom, France, Belgium
-
Canadian Cancer Trials GroupRecruiting
-
Rennes University HospitalRecruitingBlood Concentrations of Nine Anti-cancer Drugs : Axitinib, Olaparib, regorafénib, Cabozantinib, Niraparib, Talazoparib, Palbociclib, Abemaciclib, TucatinibFrance
-
First Affiliated Hospital Xi'an Jiaotong UniversityNot yet recruitingOvarian Cancer
-
H. Lee Moffitt Cancer Center and Research InstituteGlaxoSmithKlineRecruitingPenile CarcinomaUnited States
-
University of OklahomaGlaxoSmithKlineRecruitingRecurrent Ovarian Carcinoma | Recurrent Endometrial Carcinoma | ARID1A Gene MutationUnited States
-
Institut Paoli-CalmettesGlaxoSmithKlineNot yet recruiting
-
Zhejiang Cancer HospitalSun Yat-sen University; Fujian Cancer Hospital; Hunan Cancer Hospital; Zhejiang... and other collaboratorsNot yet recruitingTriple Negative Breast Cancer | Homologous Recombination Deficiency
-
North Eastern German Society of Gynaecological...Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestNot yet recruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma | Clear Cell Carcinoma
-
Centre Leon BerardGlaxoSmithKlineRecruitingMetastatic Pancreatic CancerFrance
-
Massachusetts General HospitalGlaxoSmithKlineRecruitingRecurrent Glioma | Low-grade Glioma | Glioma, Malignant | IDH2 Gene Mutation | IDH1 MutationUnited States
-
Peking Union Medical College HospitalZai Lab (Shanghai) Co., Ltd.Not yet recruiting
-
Lei LiRecruitingChemotherapy | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Niraparib | Anlotinib | CA125 | Targeted Therapy | Recurrent Ovarian CancerChina
-
Sir Mortimer B. Davis - Jewish General HospitalNot yet recruitingEndometrial Cancer | Uterine Neoplasm | Serous Adenocarcinoma
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingMetastatic Breast Cancer in Germline-PALB2 Mutations Carriers
-
K-Group, Beta, Inc., a wholly owned subsidiary...RecruitingOvarian Cancer | Fallopian Tube Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal CarcinomaUnited States, France
-
Shanghai Gynecologic Oncology GroupFudan UniversityNot yet recruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaChina
-
Seoul National University HospitalSamsung Medical Center; Takeda; Asan Medical Center; Yonsei UniversityNot yet recruitingOvarian Cancer | Epithelial Ovarian Cancer | Ovarian Cancer Stage IV | Ovarian Cancer Stage III
-
ARCAGY/ GINECO GROUPRecruitingOvarian CancerJapan, France
-
Sun Yat-sen UniversityRecruitingNasopharyngeal CarcinomaChina
-
Wuhan UniversityNot yet recruitingRecurrent Small Cell Lung Cancer